guest ::
| Home > Publications database > SARS-CoV-2 M pro inhibitors with antiviral activity in a transgenic mouse model > print |
| Home > Publications database > SARS-CoV-2 M pro inhibitors with antiviral activity in a transgenic mouse model > print |
| 001 | 471682 | ||
| 005 | 20250724175813.0 | ||
| 024 | 7 | _ | |a 10.1126/science.abf1611 |2 doi |
| 024 | 7 | _ | |a 0036-8075 |2 ISSN |
| 024 | 7 | _ | |a 1095-9203 |2 ISSN |
| 024 | 7 | _ | |a 1947-8062 |2 ISSN |
| 024 | 7 | _ | |a 10.3204/PUBDB-2021-04550 |2 datacite_doi |
| 024 | 7 | _ | |a altmetric:100405630 |2 altmetric |
| 024 | 7 | _ | |a pmid:33602867 |2 pmid |
| 024 | 7 | _ | |a WOS:000636043400052 |2 WOS |
| 024 | 7 | _ | |a openalex:W3131767541 |2 openalex |
| 037 | _ | _ | |a PUBDB-2021-04550 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 500 |
| 100 | 1 | _ | |a Qiao, Jingxin |0 0000-0002-8617-5148 |b 0 |e Corresponding author |
| 245 | _ | _ | |a SARS-CoV-2 M pro inhibitors with antiviral activity in a transgenic mouse model |
| 260 | _ | _ | |a Cambridge, Mass. |c 2021 |b Moses King |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1640680716_23122 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Vaccines are an important tool in the fight against COVID-19, but developing antiviral drugs is also a high priority, especially with the rise of variants that may partially evade vaccines. The viral protein main protease is required for cleaving precursor polyproteins into functional viral proteins. This essential function makes it a key drug target. Qiao et al. designed 32 inhibitors based on either boceprevir or telaprevir, both of which are protease inhibitors approved to treat hepatitis C virus. Six compounds protected cells from viral infection with high potency, and two of these were selected for in vivo studies based on pharmokinetic experiments. Both showed strong antiviral activity in a mouse model. |
| 536 | _ | _ | |a 6G3 - PETRA III (DESY) (POF4-6G3) |0 G:(DE-HGF)POF4-6G3 |c POF4-6G3 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, Journals: bib-pubdb1.desy.de |
| 693 | _ | _ | |a PETRA III |f PETRA Beamline P11 |1 EXP:(DE-H253)PETRAIII-20150101 |0 EXP:(DE-H253)P-P11-20150101 |6 EXP:(DE-H253)P-P11-20150101 |x 0 |
| 700 | 1 | _ | |a Li, Yue-Shan |0 P:(DE-H253)PIP1089163 |b 1 |
| 700 | 1 | _ | |a Zeng, Rui |0 0000-0001-9716-6354 |b 2 |
| 700 | 1 | _ | |a Liu, Feng-Liang |0 P:(DE-H253)PIP1081794 |b 3 |
| 700 | 1 | _ | |a Luo, Rong-Hua |0 0000-0001-9173-9991 |b 4 |
| 700 | 1 | _ | |a Huang, Chong |0 0000-0003-0951-3411 |b 5 |
| 700 | 1 | _ | |a Wang, Yi-Fei |b 6 |
| 700 | 1 | _ | |a Zhang, Jie |b 7 |
| 700 | 1 | _ | |a Quan, Baoxue |0 0000-0002-7312-2645 |b 8 |
| 700 | 1 | _ | |a Shen, Chenjian |0 0000-0002-7521-4068 |b 9 |
| 700 | 1 | _ | |a Mao, Xin |0 P:(DE-H253)PIP1080614 |b 10 |
| 700 | 1 | _ | |a Liu, Xinlei |0 0000-0001-7216-9292 |b 11 |
| 700 | 1 | _ | |a Sun, Weining |0 0000-0002-3395-7840 |b 12 |
| 700 | 1 | _ | |a Yang, Wei |0 P:(DE-H253)PIP1097882 |b 13 |
| 700 | 1 | _ | |a Ni, Xincheng |0 0000-0002-9723-4756 |b 14 |
| 700 | 1 | _ | |a Wang, Kai |0 P:(DE-H253)PIP1030760 |b 15 |
| 700 | 1 | _ | |a Xu, Ling |0 P:(DE-H253)PIP1025817 |b 16 |
| 700 | 1 | _ | |a Duan, Zi-Lei |0 0000-0002-3262-9685 |b 17 |
| 700 | 1 | _ | |a Zou, Qing-Cui |0 0000-0002-2381-9532 |b 18 |
| 700 | 1 | _ | |a Zhang, Hai-Lin |b 19 |
| 700 | 1 | _ | |a Qu, Wang |0 0000-0003-4041-9634 |b 20 |
| 700 | 1 | _ | |a Long, Yang-Hao-Peng |0 0000-0002-4167-746X |b 21 |
| 700 | 1 | _ | |a Li, Ming-Hua |b 22 |
| 700 | 1 | _ | |a Yang, Rui-Cheng |b 23 |
| 700 | 1 | _ | |a Liu, Xiaolong |0 0000-0003-1531-702X |b 24 |
| 700 | 1 | _ | |a You, Jing |0 0000-0001-9489-8947 |b 25 |
| 700 | 1 | _ | |a Zhou, Yangli |0 0000-0002-9800-7766 |b 26 |
| 700 | 1 | _ | |a Yao, Rui |0 0000-0003-4858-3551 |b 27 |
| 700 | 1 | _ | |a Li, Wen-Pei |b 28 |
| 700 | 1 | _ | |a Liu, Jing-Ming |b 29 |
| 700 | 1 | _ | |a Chen, Pei |0 0000-0002-7710-6837 |b 30 |
| 700 | 1 | _ | |a Liu, Yang |b 31 |
| 700 | 1 | _ | |a Lin, Gui-Feng |0 0000-0002-2888-6099 |b 32 |
| 700 | 1 | _ | |a Yang, Xin |b 33 |
| 700 | 1 | _ | |a Zou, Jun |0 0000-0002-5395-6052 |b 34 |
| 700 | 1 | _ | |a Li, Linli |0 0000-0001-7743-434X |b 35 |
| 700 | 1 | _ | |a Hu, Yiguo |0 0000-0002-3973-2140 |b 36 |
| 700 | 1 | _ | |a Lu, Guang-Wen |0 0000-0001-7568-592X |b 37 |
| 700 | 1 | _ | |a Li, Wei-Min |b 38 |
| 700 | 1 | _ | |a Wei, Yu-Quan |0 0000-0002-6211-3217 |b 39 |
| 700 | 1 | _ | |a Zheng, Yong-Tang |0 0000-0001-5469-0324 |b 40 |
| 700 | 1 | _ | |a Lei, Jian |b 41 |
| 700 | 1 | _ | |a Yang, Shengyong |0 0000-0001-5147-3746 |b 42 |
| 773 | _ | _ | |a 10.1126/science.abf1611 |g Vol. 371, no. 6536, p. 1374 - 1378 |0 PERI:(DE-600)2066996-3 |n 6536 |p 1374 - 1378 |t Science |v 371 |y 2021 |x 0036-8075 |
| 856 | 4 | _ | |y OpenAccess |u https://bib-pubdb1.desy.de/record/471682/files/science.abf1611.pdf |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://bib-pubdb1.desy.de/record/471682/files/science.abf1611.pdf?subformat=pdfa |
| 909 | C | O | |o oai:bib-pubdb1.desy.de:471682 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a European Molecular Biology Laboratory |0 I:(DE-588b)235011-7 |k EMBL |b 1 |6 P:(DE-H253)PIP1089163 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 1 |6 P:(DE-H253)PIP1089163 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 3 |6 P:(DE-H253)PIP1081794 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 10 |6 P:(DE-H253)PIP1080614 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 13 |6 P:(DE-H253)PIP1097882 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 15 |6 P:(DE-H253)PIP1030760 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 16 |6 P:(DE-H253)PIP1025817 |
| 913 | 1 | _ | |a DE-HGF |b Forschungsbereich Materie |l Großgeräte: Materie |1 G:(DE-HGF)POF4-6G0 |0 G:(DE-HGF)POF4-6G3 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-600 |4 G:(DE-HGF)POF |v PETRA III (DESY) |x 0 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2021-02-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2021-02-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |d 2021-02-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1200 |2 StatID |b Chemical Reactions |d 2021-02-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2021-02-02 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b SCIENCE : 2019 |d 2021-02-02 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2021-02-02 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1060 |2 StatID |b Current Contents - Agriculture, Biology and Environmental Sciences |d 2021-02-02 |
| 915 | _ | _ | |a IF >= 40 |0 StatID:(DE-HGF)9940 |2 StatID |b SCIENCE : 2019 |d 2021-02-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2021-02-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2021-02-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2021-02-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1150 |2 StatID |b Current Contents - Physical, Chemical and Earth Sciences |d 2021-02-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1210 |2 StatID |b Index Chemicus |d 2021-02-02 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-02-02 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a National-Konsortium |0 StatID:(DE-HGF)0430 |2 StatID |d 2021-02-02 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2021-02-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-02-02 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2021-02-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-02-02 |
| 920 | 1 | _ | |0 I:(DE-H253)HAS-User-20120731 |k DOOR ; HAS-User |l DOOR-User |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-H253)HAS-User-20120731 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|